DYRK2 and colorectal carcinoma: Ito et al. reported for the first time that the overexpression of DYRK2 inhibits CRC liver metastasis, indicating that patients undergoing the resection of CRC liver metastases who have lower levels of DYRK2 may require closer surveillance as compared to those with high levels of DYRK220.